India's first approved hepatitis E vaccine reached the market in January 2026. Hepatitis E causes up to 40 per cent of acute hepatitis and a large share of acute liver failure in India, and until this year there was nothing to offer at all.
A three-dose series. Licensed in India for adults aged 18 to 65.
For women of childbearing age the timing matters: complete the course before conception, not during pregnancy.
| Brand | What is in it | Per dose |
|---|---|---|
| Hevaxin 0.5 ml Our choice Dr Reddy's Laboratories | Recombinant hepatitis E vaccine, 0.5 ml single-dose pack. Licensed for adults 18 to 65 The only hepatitis E vaccine approved in India. Manufactured by Xiamen Innovax Biotech and imported; marketed here by Dr Reddy's. | ₹7,225 |
There is no alternative. This is the only hepatitis E vaccine approved in India, launched in January 2026. It is a three-dose course at this price per dose, so it is a significant commitment and we will only suggest it where the case is genuinely strong: chronic liver disease, immunosuppression, pre-transplant assessment, or a woman planning a pregnancy.
Product names and prices are listed so you know what you are being given and what it costs. They are for identification only and do not constitute a recommendation of any manufacturer. Prices shown are the manufacturer's maximum retail price per dose as at 12 August 2026; manufacturers and the National Pharmaceutical Pricing Authority revise these from time to time, and your actual cost is confirmed before anything is administered.
Guidance this page reflects. Manufacturer's approved Indian indication, January 2026; World Health Organization SAGE background paper on hepatitis E, March 2024. Last reviewed 12 August 2026.
Vaccines are prescription medicines. Suitability, timing and contraindications are determined by a doctor after individual assessment. This page is general information about a clinical service and is not a prescription, a recommendation to purchase any product, or a substitute for consultation.
Most adults are missing two or three. Two questions will tell you which to raise.